Treasury yields climb amid further Covid-19 vaccine developments

Treasury yields rose after news of an effective coronavirus vaccine from AstraZeneca and hopes that people in the U.S. could start being immunized in December.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.